Pharmaceutical giant GSK recently announced the formation of a $50 million venture capital fund, Action Potential Venture Capital (APVC) Limited, ...

Last week, a major pharmaceutical company, Eisai Inc., sued the Drug Enforcement Administration (DEA), the very agency that stands between ...

From time to time in this blog, I discuss the tremendous value of proper talent management discipline. In my most ...

Earlier in our blog series “The Dimensions of Doing Good”, we discussed how transparency is created through Life Cycle Assessments ...

Connecting master data management with sustainability – is it a far reach?  I don’t think so.  When a company has ...

In the case of Mutual Pharmaceutical Co. Inc. v. Bartlett, the Supreme Court overturned a lower court ruling that awarded ...

Fortune 500 CEO Indra Nooyi recently provided her perspectives on sustainable capitalism at the ICGN Annual Conference in New York ...

Biosimilars are coming to the US. Although the details on the pathway for biosimilars are still being finalized, the cost ...

The countdown is on, literally, to “the sweetest comeback in the history of ever.”  Twinkies are expected to return to ...

The economics of pay-for-delay agreements are clear – branded drug makers benefit from an extended amount of time on the ...

In one of my earlier blogs, Removing the Mystery for Serialization Stakeholders, I talked about the need to identify internal ...

Clarkston sponsored last week’s annual Consumer Goods Technology (CGT) Sales and Marketing Summit, Datatopia: From Big Data to Meaningful Customer ...